Literature DB >> 12097943

TAT peptide-modified liposomes for intracellular delivery of drugs and DNA.

Vladimir P Torchilin1.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 12097943

Source DB:  PubMed          Journal:  Cell Mol Biol Lett        ISSN： 1425-8153            Impact factor:   5.787


× No keyword cloud information.
  8 in total

1.  Interaction of α-synuclein and a cell penetrating fusion peptide with higher eukaryotic cell membranes assessed by ¹⁹F NMR.

Authors:  Imola G Zigoneanu; Gary J Pielak
Journal:  Mol Pharm       Date:  2012-03-13       Impact factor: 4.939

Review 2.  Carrier-based strategies for targeting protein and peptide drugs to the lungs.

Authors:  Sally-Ann Cryan
Journal:  AAPS J       Date:  2005-03-24       Impact factor: 4.009

3.  Targeting ischemic penumbra Part II: selective drug delivery using liposome technologies.

Authors:  Shimin Liu; Steven R Levine; H Richard Winn
Journal:  J Exp Stroke Transl Med       Date:  2011

4.  HIV TAT Protein Transduction Domain Mediated Cell Binding and Intracellular Delivery of Nanoparticles.

Authors:  J Andrew Mackay; Francis C Szoka
Journal:  J Dispers Sci Technol       Date:  2003       Impact factor: 2.262

5.  Environment-Responsive Polymers for Coating of Pharmaceutical Nanocarriers(,).

Authors:  A A Kale; V P Torchilin
Journal:  Polym Sci Ser A Chem Phys       Date:  2009-06

6.  Tat peptide is capable of importing large nanoparticles across nuclear membrane in digitonin permeabilized cells.

Authors:  Nitin Nitin; Leslie LaConte; Won Jong Rhee; Gang Bao
Journal:  Ann Biomed Eng       Date:  2009-08-06       Impact factor: 3.934

7.  In vitro transfection of bone marrow-derived dendritic cells with TATp-liposomes.

Authors:  Juan Sebastián Pappalardo; Cecilia A Langellotti; Sebastián Di Giacomo; Valeria Olivera; Valeria Quattrocchi; Patricia I Zamorano; William C Hartner; Tatyana S Levchenko; Vladimir P Torchilin
Journal:  Int J Nanomedicine       Date:  2014-02-13

8.  Lipid-peptide vesicle nanoscale hybrids for triggered drug release by mild hyperthermia in vitro and in vivo.

Authors:  Zahraa S Al-Ahmady; Wafa' T Al-Jamal; Jeroen V Bossche; Tam T Bui; Alex F Drake; A James Mason; Kostas Kostarelos
Journal:  ACS Nano       Date:  2012-08-15       Impact factor: 15.881
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.